Ischemia/reperfusion injury for decades has remained a very important clinical issue and a hot topic for research in organ transplantation. While for years it was called non-immunological injury, we already know that it adds importantly to immunity of a transplanted organ, its antigen presentation, and hence rejection and chronic injury. Ischemia/reperfusion remains a leading cause of early renal graft dysfunction and causes myocardial stunning in heart transplantation and biliary complications after liver transplantation. Due to increasing number of patients on the waiting list and the shortage of organs in recent years, expanded categories of donors have been used. This urge is expected to increase the risk of complications and affect patient safety and cost-effectiveness of transplantation.

Although tremendous progress was made in understanding the mechanism of ischemia/reperfusion injury, effective prevention of this phenomenon in the clinical setting is still difficult.

As this is definitely not a closed chapter, we encourage authors to submit both review and original articles from human and animal studies that will help understand mechanisms of ischemia/ reperfusion injury, its consequences to the auto-/allo-/xenograft models, and develop methods which would allow for some protection of the organ. Potential topics include, but are not limited to:

• Mechanisms of tissue injury resulting from ischemia and reperfusion
• Genetics and “omics” of a transplant ischemia/reperfusion
• Ischemia-reperfusion injury in organs from donors after circulatory definition of death
• Viability testing of NHBD-grafts
• Impact of donor pretreatment on ischemia/reperfusion of a transplanted organ
• Interrelations of ischemia/reperfusion and immunological graft injury
• Progress in organ preservation technology